✦ LIBER ✦

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia

✍ Scribed by Österborg, A; Foà, R; Bezares, R F; Dearden, C; Dyer, M J S; Geisler, C; Lin, T S; Montillo, M; van Oers, M H J; Wendtner, C-M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Management Guidelin

✍ A. Oesterborg; R. Foa; R. F. Bezares; C. Dearden; M. J. S. Dyer; C. Geisler; T. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 15 KB

Management Guidelines for Use of Alemtuz

✍ Keating, Michael; Coutré, Stephen; Rai, Kanti; Österborg, Anders; Faderl, Stefan 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 172 KB

Updated Guidelines on the Management of

✍ O'Brien, Susan M.; Keating, Michael J.; Mocarski, Edward S. 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 140 KB

The Emerging Role of Alemtuzumab in Chro

✍ Nabhan, Chadi 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 890 KB

Management of infections in patients wit

✍ Thomas Elter; Janne J. Vehreschild; John Gribben; Oliver A. Cornely; Andreas Eng 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 221 KB

The use of low-dose alemtuzumab in pretr

✍ Tarnani, M; D'Arena, G; Efremov, D G; Marietti, S; S, Sica; Leone, G; Laurenti, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB